scholarly journals The prevalence of hyperglycemia in neonatal hypernatremic dehydration (NHD) and its correlation with prognosis in exclusively breastfed infants: A cohort study

2020 ◽  
Vol 41 (6) ◽  
pp. 249
Author(s):  
Hassan Boskabadi ◽  
Maryam Zakerihamidi
Keyword(s):  
Cohort Study ◽  
Breastfed Infants ◽  
Hypernatremic Dehydration

scholarly journals Effect of exclusive breastfeeding and complementary feeding on infant growth and morbidity

2004 ◽  
Vol 10 (3) ◽  
pp. 289-294
Author(s):  
T. Khadivzadeh ◽  
S. Parsai
Keyword(s):  
Cohort Study ◽  
Breast Milk ◽  
Exclusive Breastfeeding ◽  
Complementary Feeding ◽  
Respiratory Infections ◽  
Islamic Republic ◽  
Breastfed Infants ◽  
Height Gain ◽  
Islamic Republic Of Iran ◽  
Infants Feeding

A cohort study was conducted in the Islamic Republic of Iran between January 1997 and February 1998 to compare the growth and morbidity of 100 infants who were exclusively breastfed for 6 months and 100 who received breast milk and complementary foods between 4-6 months. Infants’ feeding pattern, weight and height were assessed and recorded. There were no significant differences in infants’ weight and height gain between 4 and 6 months. The rate of diarrhoea between ages 4 and 6 months was significantly lower in exclusively breastfed infants than in complementary food-fed infants [11% versus 27%] and respiratory infections were also lower [23% versus 35%]. We conclude that exclusive breastfeeding is superior at least until an infant is 6 months of age

scholarly journals Breastfeeding exclusively and iron deficiency anemia during the first 6 months of age

2014 ◽  
Vol 60 (1) ◽  
pp. 18-22 ◽  
Author(s):  
Rosa F.S.V. Marques ◽  
José A.A.C. Taddei ◽  
Fábio A. Lopez ◽  
Josefina A.P. Braga
Keyword(s):  
Risk Factors ◽  
Cohort Study ◽  
Iron Deficiency ◽  
Iron Deficiency Anemia ◽  
Exclusive Breastfeeding ◽  
Deficiency Anemia ◽  
Term Infants ◽  
Breastfed Infants ◽  
Growth Development ◽  
Associated Risk Factors

Objective The objective was to determine the prevalence of iron deficiency and iron deficiency anemia among exclusively breastfed infants from one to six months of life and to identify associated risk factors. Methods This is a cohort study of the hemoglobin and serum ferritin levels of 102 healthy full-term infants, weighing more than 2500 grams (5.5 pounds) at birth, evaluated for growth development and supported to promote exclusive breastfeeding. Hemoglobin and ferritin levels were measured in the first, fourth, and sixth months of life. The hemoglobin and ferritin levels of the mothers were also measured in the first month postpartum. Results At four months, 5.7% presented iron deficiency and 3.4% had iron deficiency anemia. At six months, the percentage of children with iron deficiency increased more than four times, reaching 26.1%, while iron deficiency anemia was present in 23.9% of the infants studied. Iron deficiency at six months of age was significantly correlated to growth velocity. Conclusion According to the results of this study, exclusive breastfeeding protects infants from iron deficiency and iron deficiency anemia for the first four months of life. After this age, in accordance with the literature, the findings of this study demonstrated an increase in anemia and iron deficiency rates, adding to evidence that supports the monitoring of iron levels in exclusively breastfed children presenting higher weight gains beginning at four months of age.

scholarly journals Comparison of SARS-CoV-2-Specific Antibodies in Human Milk after mRNA-Based COVID-19 Vaccination and Infection

Vaccines ◽  
2021 ◽  
Vol 9 (12) ◽  
pp. 1475
Author(s):  
Hannah G. Juncker ◽  
Sien J. Mulleners ◽  
Marit J. van Gils ◽  
Tom P. L. Bijl ◽  
Christianne J. M. de Groot ◽  
...  
Keyword(s):  
Cohort Study ◽  
Antibody Response ◽  
Human Milk ◽  
Breastfed Infant ◽  
Longitudinal Cohort Study ◽  
Lactating Women ◽  
Longitudinal Cohort ◽  
Specific Antibodies ◽  
Breastfed Infants ◽  
Milk Samples

SARS-CoV-2-specific antibodies are secreted into human milk of infected or vaccinated lactating women and might provide protection to the breastfed infant against COVID-19. Differences in antibody response after these types of exposure are unknown. In this longitudinal cohort study, we compared the antibody response in human milk following SARS-CoV-2 vaccination or infection. We analyzed 448 human milk samples of 28 lactating women vaccinated with the SARS-CoV-2 vaccine BNT162b2 as well as 82 human milk samples of 18 lactating women with a prior SARS-CoV-2 infection. The levels of SARS-CoV-2-specific IgA in human milk were determined over a period of 70 days both after vaccination and infection. The amount of SARS-CoV-2-specific IgA in human milk was similar after SARS-CoV-2 vaccination and infection. After infection, the variability in IgA levels was higher than after vaccination. Two participants with detectable IgA prior to vaccination were analyzed separately and showed higher IgA levels following vaccination compared to both groups. In conclusion, breastfed infants of mothers who have been vaccinated with the BNT162b2 vaccine receive human milk with similar amounts of SARS-CoV-2-specific antibodies compared to infants of previously infected mothers.

scholarly journals The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns: A Prospective Cohort Study

2021 ◽  
Vol 8 ◽  
pp. 2333794X2110441
Author(s):  
Karina Merini Tonon ◽  
Thaís Moreno Tomé ◽  
Elaine Martins Bento Mosquera ◽  
Natália Pratis Perina ◽  
Tamara Lazarini
Keyword(s):  
Cohort Study ◽  
Weight Gain ◽  
Gastrointestinal Symptoms ◽  
Artificial Feeding ◽  
Additional Benefit ◽  
Infant Formulas ◽  
Breastfed Infants ◽  
Healthy Infants ◽  
Clinical Benefits ◽  
Medical Recommendation

There is a lack of studies investigating the clinical benefits of prebiotic-supplemented infant formula. In this study, healthy infants that started, on medical recommendation, artificial feeding with one of 2 infant formulas containing 4 g/L of GOS/FOS (9:1) (IF4 group; n = 60) or 8 g/L of GOS/FOS (9:1) (IF8 group; n = 60) were followed for 30 days to the evaluation of growth and gastrointestinal symptoms. Exclusively breastfed infants (EBF; n = 60) were followed up as a reference. Both infant formulas supported adequate weight gain, however, IF4 formula promotes growth more similar to breastfed infants. There was no additional benefit of a dose higher than 4 g/L of GOS/FOS on gastrointestinal symptoms.

Natural history of helicobacter pylori infection from infancy to adulthood: A 21-year follow-up cohort study

2001 ◽  
Vol 120 (5) ◽  
pp. A128-A128 ◽  
Author(s):  
H MALATY ◽  
D GRAHAM ◽  
A ELKASABANY ◽  
S REDDY ◽  
S SRINIVASAN ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Cohort Study ◽  
Natural History ◽  
Helicobacter Pylori Infection ◽  
History Of

Tu1788 CLINICAL CHARACTERISTICS AND TREATMENT DIFFERENCES BETWEEN YOUNGER AND OLDER ONSET MICROSCOPIC COLITIS: A MULTICENTER RETROSPECTIVE COHORT STUDY

2020 ◽  
Vol 158 (6) ◽  
pp. S-1161
Author(s):  
Amrit K. Kamboj ◽  
Amandeep Gujral ◽  
Elida Voth ◽  
Daniel Penrice ◽  
Jessica McGoldrick ◽  
...  
Keyword(s):  
Cohort Study ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Clinical Characteristics ◽  
Microscopic Colitis
Sign in / Sign up

Export Citation Format

Share Document